Q&A With BeneVir Co-Founder, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1)

Published on :

Q&A With BeneVir Co-Founder and COO, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1) October 9, 2018 This has been a year marked by many notable biotech deals, especially in the immunotherapy market.  One deal, in particular, has generated more local excitement in the BioHealth Capital Region than any other; that is [….]